Dr. Heather Chelsey Futral, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 4073 Highway 53, Hoschton, GA 30548 Phone: 770-882-5884 Fax: 706-658-0116 |
Dr. Deborah Gunnin, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4073 Highway 53, Hoschton, GA 30548 Phone: 770-882-5884 Fax: 706-658-0116 |
Robin Hardin, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4073 Highway 53, Hoschton, GA 30548 Phone: 770-882-5884 Fax: 706-658-0116 |
News Archive
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
URS Corporation, a global engineering and construction firm serving both private and public sector organizations, has been awarded the Corporate Health Achievement Award (CHAA) Exemplary Practice Citation by the American College of Occupational and Environmental Medicine (ACOEM). URS Corporation received the citation for its outstanding efforts in promoting employee health, wellness, and safety.
Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced the results of a Phase II trial to evaluate the effects of OHR/AVR118 in advanced cancer patients with cachexia. Cancer cachexia is the complex, multi-symptom syndrome seen in late-stage cancer patients, characterized by anorexia and unintended loss of appetite, progressive and continual weight loss, accompanied by generalized host tissue wasting, skeletal muscle atrophy, immune and metabolic dysfunction, and a greatly diminished quality of life.
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Bright Now! Dental office in Tampa, FL. This new office marks the 25th office in the state of Florida.
› Verified 3 days ago